Therapeutic Potential of Human Microbiome-Based Short-Chain Fatty Acids and Bile Acids in Liver Disease

Therapeutic Potential of Human Microbiome-Based Short-Chain Fatty Acids and Bile Acids in Liver Disease

Microbiome-derived short chain fatty acids (SCFAs: acetate, propionate, and butyrate) and bile acids (BAs: primary BAs and secondary BAs) widely influence liver metabolic inflammation, immune responses, and carcinogenesis. In recent literature, the role of SCFAs and BAs in various liver diseases has...

Full description

Bibliographic Details
Main Authors: Raja Ganesan, Ki Tae Suk
Format: Article
Language:English
Published: MDPI AG 2022-08-01
Series:Livers
Subjects:
short-chain fatty acids
bile acids
liver therapies
metabolomics
metabolic discriminations
biochemistry
Online Access:https://www.mdpi.com/2673-4389/2/3/12

Internet

https://www.mdpi.com/2673-4389/2/3/12

Similar Items